Perceptive Capital Solutions Corp - Ordinary Shares - Class A
PCSC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$101.09M
Close$
$0.10
99.2% downside
Current Fair Value
99.2% downsideOvervalued by 99.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $101.09 Million |
|---|---|
| Enterprise Value | $100.65 Million |
| Earnings per Share | $0.08 |
| Beta | 0.36 |
| Outstanding Shares | 8,459,284 |
Return
| Return on Equity | 12.11% |
|---|---|
| Return on Assets | -0.89% |
| Return on Invested Capital | -4.26% |
Valuation & Multiples
| P/E Ratio | -168.55 |
|---|---|
| PEG | 146.27 |
| Price to Sales | - |
| Price to Book Ratio | -11.95 |
| Enterprise Value to Revenue | 121.8 |
| Enterprise Value to EBIT | -28.71 |
| Enterprise Value to Net Income | -132 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 104.00%▼ 13.33% |
|---|---|
| Total Invested | $95.74M▼ 13.75% |
| Investors Holding | 27▼ 7.00% |
About Perceptive Capital Solutions Corp
378 employees
CEO: Aaron Elliott
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA me...